Author:
Bell Diana,Afkhami Michelle
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Cantù G (2023) Nasopharyngeal carcinoma. A “different” head and neck tumour. Part B: treatment, prognostic factors and outcomes. Acta Otorhinolaryngol Ital 43(3):155–169
2. Chan JKC, Bray F, Lee AWM, Lo KV, Petersson BF, Rajadurai P (2024) Nasopharyngeal carcinoma. In: Head and neck tumours. WHO classification of tumours, 5th edn., vol 9. International Agency for Research on Cancer, Lyon, France
3. Skalova A, Agaimy A, Bradova M et al (2024) Molecularly defined sinonasal malignancies: an overview with focus on the current WHO classification and recently described provisional entities. Virchows Arch 484(6):885–900
4. Chung GT, Lung RW, Hui AB (2013) Identification of a recurrent transforming UBR5-ZNF423 fusion gene in EBV-associated nasopharyngeal carcinoma. J Pathol 231(2):158–167
5. Zhong Q, Liu ZH, Lin ZR (2018) The RARS-MAD1L1 fusion gene induces cancer stem cell-like properties and therapeutic resistance in nasopharyngeal carcinoma. Clin Cancer Res 24(3):659–673